mSix&Partners wins integrated media mandate for Dr Reddy's OTC Business

The mandate was won after a multi-agency selection process and will be managed by the agency's Mumbai office

author-image
BestMediaInfo Bureau
Updated On
New Update
mSix&Partners wins integrated media mandate for Dr Reddy's OTC Business

mSix&Partners, GroupM's youngest agency, has won the integrated media mandate for Dr. Reddy's OTC Business.

The account will be managed by the agency's Mumbai office, which will leverage its data and tech-driven approach to drive business growth for the client through targeted media planning and execution.

With a focus on maximising ROI for the client, mSix&Partners plans to use its experience in media planning, execution, and measurement to craft solutions that resonate with Dr. Reddy's regional audience.

The mandate will focus on crafting micro-marketing solutions with a clear focus on the regionalisation story for Reblanz ORS brands.

Subhamay Mukhopadhyay, Managing Partner, mSix&Partners India, said, "We are thrilled to partner with Dr. Reddy's and bring our data-driven approach to the table. As a data and tech-driven agency, we understand the importance of driving business growth through bespoke, dedicated, multi-disciplinary teams that closely partner with our clients. Our data-driven approach is what sets us apart, and we're excited to bring that to the table for Dr. Reddy's. We look forward to adding value through our expertise in media planning and execution to deliver on the client's objectives."

Nigel Saldanha , Head of Marketing OTC, GG India for Dr. Reddy’s, said “We are on a very interesting journey in building an OTC business at Dr. Reddy’s GG India, and at this juncture, having the right partners on board is of paramount importance. After rigorous evaluations, we are happy to award the integrated media mandate to mSix&Partners India and look forward to accelerating our ambitions through this partnership."

Info@BestMediaInfo.com

GroupM Mumbai office Media mandate mSix&Partners Dr Reddy OTC business Reblanz ORS
Advertisment